Biontech Se ADR (BNTX)

$111.30 -0.10 (-0.09%)
Market Cap 26.78B
Revenue (ttm) 2.98B
Net Income (ttm) -719.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.18%
Debt to Equity Ratio 0.01
Volume 1,006,700
Avg Vol 692,078
Day's Range N/A - N/A
Shares Out 240.40M
Stochastic %K 49%
Beta 1.23
Analysts Strong Sell
Price Target $135.41

Company Profile

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical tri...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 6131 9084
Fax: 49 6131 9084
Address:
An der Goldgrube 12, Mainz, Germany
taxplanr
taxplanr Aug. 21 at 10:45 AM
CDC stoking another attack $BNTX $MRNA $PFE Brilliant https://www.axios.com/2025/08/21/cdc-shooting-robert-f-kennedy-rfk-jr-health-workers
0 · Reply
Arcides
Arcides Aug. 21 at 12:52 AM
$BNTX Bio name with first base, still in progress, need some tightness
0 · Reply
taxplanr
taxplanr Aug. 20 at 2:45 AM
C19 bioweapon injured "Turbo Cancer" defined in study $BNTX $MRNA $PFE https://www.thefocalpoints.com/p/first-peer-reviewed-paper-defines
0 · Reply
Quantumup
Quantumup Aug. 19 at 8:14 PM
Piper Sandler y'day🏁 $JANX Overweight-$42 and said that it continues to think JANX007 is 'a differentiated, potentially best-in-class program' in metastatic castration-resistant prostate cancer (mCRPC). $JNJ $AZN $BNTX $MRK BMY Piper Sandler said in its $JANX initiation: Following highly positive reception to JANX007 clinical data in mCRPC in December 2024, investor sentiment has waned over the course of 2025 following the emergence of competitor clinical data, and the announcement of completion of the JANX007 dose escalation. We continue to think JANX007 is a differentiated, potentially best-in-class program in mCRPC and see the stock pull-back as offering an attractive entry point as we head into the clinical update later this year.
0 · Reply
taxplanr
taxplanr Aug. 19 at 7:46 PM
For anyone who thought teaching your body to make spike proteins $BNTX $MRNA $PFE here is the spike effect guide https://cdn.shopify.com/s/files/1/0649/7658/4920/files/The_Spike_Protein_Effect_Guide-v2r.pdf
0 · Reply
taxplanr
taxplanr Aug. 19 at 10:50 AM
BREAKING there are 2 doctors in the US who care about people $BNTX $MRNA $PFE https://justthenews.com/politics-policy/health/two-physicians-sue-cdc-over-aggressive-child-vaccine-program?utm_source=mux&utm_medium=social-media&utm_campaign=social-media-autopost
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Aug. 19 at 9:47 AM
WATCHLIST AUG 19 2025 $CELZ Creative Medical Technologies will be issued US patent number 12,391,925 tomorrow titled "PREVENTION AND/OR TREATMENT OF TYPE 1 DIABETES BY AUGMENTATION OF MYELOID SUPPRESSOR CELL ACTIVITY" $TATT TAT Technologies Wins Three-Year Contract with an International Airline to Provide MRO Services For The GTCP331-500 Auxiliary Power Unit Used In The Boeing 777 Platform; Valued At $4M/Year, Or $12M $HIVE HIVE Digital Technologies Subsidiary BUZZ HPC Partners With Bell Canada To Deliver Advanced Sovereign NVIDIA AI Infrastructure For Canada $BNTX Pfizer Canada ULC And BioNTech SE Announced Today That Health Canada Has Authorized The LP. 8.1 Variant Adapted Comirnaty COVID-19 Vaccine For Individuals Aged 6 Months And Older $VSAT Viasat Secures $252M AUD Award From Geoscience Australia And Land Information New Zealand To Deliver Expanded SouthPAN Satellite Services
1 · Reply
taxplanr
taxplanr Aug. 19 at 1:17 AM
CDC being sued over illegal childhood vaccine schedule $BNTX $MRNA $PFE https://www.thefocalpoints.com/p/breaking-cdc-sued-for-pushing-illegal
2 · Reply
smartkarma
smartkarma Aug. 18 at 10:38 PM
$BNTX | BioNTech SE: An Insight Into The BNT327 Combination Trials In Oncology "The company has made significant strides in oncology, indicating a diversified approach beyond its known COVID-19 vaccine success." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/biontech-se-an-insight-into-the-bnt327-combination-trials-in-oncology
0 · Reply
taxplanr
taxplanr Aug. 18 at 4:54 PM
$BNTX $MRNA $PFE C19 bioweapons causing blindness https://www.thefocalpoints.com/p/breaking-covid-19-mrna-shots-destroy-087
2 · Reply
Latest News on BNTX
CureVac settles patent dispute litigation with Pfizer and BioNTech

Aug 7, 2025, 9:00 PM EDT - 13 days ago

CureVac settles patent dispute litigation with Pfizer and BioNTech

CVAC PFE

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

Aug 5, 2025, 1:36 PM EDT - 15 days ago

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 1:56 PM EDT - 16 days ago

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

Aug 4, 2025, 10:32 AM EDT - 17 days ago

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

Aug 4, 2025, 7:01 AM EDT - 17 days ago

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

BioNTech's Q2 revenues double on higher COVID vaccine sales

Aug 4, 2025, 6:52 AM EDT - 17 days ago

BioNTech's Q2 revenues double on higher COVID vaccine sales

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Aug 4, 2025, 6:45 AM EDT - 17 days ago

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Aug 1, 2025, 4:51 PM EDT - 19 days ago

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

MRNA PFE

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

Aug 1, 2025, 8:31 AM EDT - 20 days ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

President Trump demands drugmakers slash prices within 60 days

Aug 1, 2025, 6:54 AM EDT - 20 days ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Aug 1, 2025, 5:59 AM EDT - 20 days ago

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

MRNA PFE

Pandemic darlings Moderna, BioNTech are now on two different paths

Jul 31, 2025, 7:00 AM EDT - 21 days ago

Pandemic darlings Moderna, BioNTech are now on two different paths

MRNA

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 27 days ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 27 days ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union

PFE

8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth

Jul 23, 2025, 4:11 AM EDT - 4 weeks ago

8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth

PFE

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

Jul 21, 2025, 6:45 AM EDT - 4 weeks ago

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

BioNTech Announces Ryan Richardson to Step Down from the Management Board

Jul 17, 2025, 8:30 AM EDT - 5 weeks ago

BioNTech Announces Ryan Richardson to Step Down from the Management Board

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

Jul 10, 2025, 7:18 AM EDT - 6 weeks ago

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

MRNA PFE

5 Stocks To Ride The German Market Rally

Jun 16, 2025, 3:06 PM EDT - 2 months ago

5 Stocks To Ride The German Market Rally

FMS SAP

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal

Jun 12, 2025, 11:07 AM EDT - 2 months ago

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal

CVAC

BioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising.

Jun 12, 2025, 7:11 AM EDT - 2 months ago

BioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising.

CVAC

BioNTech to acquire CureVac in $1.25 billion all-stock deal

Jun 12, 2025, 7:03 AM EDT - 2 months ago

BioNTech to acquire CureVac in $1.25 billion all-stock deal

CVAC

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

Jun 12, 2025, 6:45 AM EDT - 2 months ago

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say

Jun 10, 2025, 11:50 AM EDT - 2 months ago

RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say

MRK MRNA PFE

Vaccine actions and policy positions under US Health Secretary Kennedy

Jun 10, 2025, 10:45 AM EDT - 2 months ago

Vaccine actions and policy positions under US Health Secretary Kennedy

MRNA NVAX PFE

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

Jun 10, 2025, 9:30 AM EDT - 2 months ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

MRNA NVAX PFE

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

Jun 10, 2025, 8:18 AM EDT - 2 months ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

MRNA NVAX PFE SNY

Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment

Jun 6, 2025, 7:00 AM EDT - 2 months ago

Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment

BMY

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

Jun 3, 2025, 3:34 PM EDT - 2 months ago

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

AZN GILD PFE AMGN BMY MRK

Bristol Myers CEO explains why he's spending billions on BioNTech deal

Jun 2, 2025, 3:50 PM EDT - 2 months ago

Bristol Myers CEO explains why he's spending billions on BioNTech deal

BMY

Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz

Jun 2, 2025, 2:51 PM EDT - 2 months ago

Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz

BMY BPMC MRK SNY

Bristol Myers Squibb CEO on $11B cancer drug deal with BioNTech

Jun 2, 2025, 12:22 PM EDT - 2 months ago

Bristol Myers Squibb CEO on $11B cancer drug deal with BioNTech

BMY

Bristol Myers CEO on Biontech deal: Next new frontier in treatment of cancer

Jun 2, 2025, 11:08 AM EDT - 2 months ago

Bristol Myers CEO on Biontech deal: Next new frontier in treatment of cancer

BMY

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race

Jun 2, 2025, 8:46 AM EDT - 2 months ago

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race

BMY

BioNTech Sets Cancer-Drug Deal With Bristol Myers Squibb

Jun 2, 2025, 7:42 AM EDT - 2 months ago

BioNTech Sets Cancer-Drug Deal With Bristol Myers Squibb

BMY

Bristol Myers to pay $1.5 billion upfront for BioNTech cancer drug partnership

Jun 2, 2025, 6:50 AM EDT - 2 months ago

Bristol Myers to pay $1.5 billion upfront for BioNTech cancer drug partnership

BMY

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting

May 27, 2025, 8:15 AM EDT - 3 months ago

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting

BioNTech plans up to $1.33 billion investment in the United Kingdom

May 20, 2025, 9:09 AM EDT - 3 months ago

BioNTech plans up to $1.33 billion investment in the United Kingdom

New vaccine chief rocks pharmaceutical stocks

May 7, 2025, 11:13 AM EDT - 3 months ago

New vaccine chief rocks pharmaceutical stocks

MRNA NVAX PFE GSK IBB SRPT XBI

BioNTech: mRNA Challenges Amid Regulatory Uncertainty (Rating Downgrade)

May 6, 2025, 7:45 AM EDT - 3 months ago

BioNTech: mRNA Challenges Amid Regulatory Uncertainty (Rating Downgrade)

BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion

May 5, 2025, 3:49 PM EDT - 3 months ago

BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion

BioNTech SE (BNTX) Q1 2025 Earnings Call Transcript

May 5, 2025, 11:39 AM EDT - 3 months ago

BioNTech SE (BNTX) Q1 2025 Earnings Call Transcript

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update

May 5, 2025, 6:45 AM EDT - 3 months ago

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update

BioNTech says Novartis executive Zapata-Gomez to become CFO

May 5, 2025, 6:34 AM EDT - 3 months ago

BioNTech says Novartis executive Zapata-Gomez to become CFO

NVS

BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

May 5, 2025, 6:30 AM EDT - 3 months ago

BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025

Apr 24, 2025, 6:45 AM EDT - 4 months ago

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025

Apr 22, 2025, 6:45 AM EDT - 4 months ago

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025

Vaccine stocks fall following FDA resignation

Mar 31, 2025, 6:21 PM EDT - 5 months ago

Vaccine stocks fall following FDA resignation

MRNA NVAX PFE PCVX PTCT XBI

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views

Mar 31, 2025, 2:41 PM EDT - 5 months ago

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views

MRNA NVAX PFE

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

Mar 31, 2025, 2:25 PM EDT - 5 months ago

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

NVAX SLDB SRPT TSHA XBI

taxplanr
taxplanr Aug. 21 at 10:45 AM
CDC stoking another attack $BNTX $MRNA $PFE Brilliant https://www.axios.com/2025/08/21/cdc-shooting-robert-f-kennedy-rfk-jr-health-workers
0 · Reply
Arcides
Arcides Aug. 21 at 12:52 AM
$BNTX Bio name with first base, still in progress, need some tightness
0 · Reply
taxplanr
taxplanr Aug. 20 at 2:45 AM
C19 bioweapon injured "Turbo Cancer" defined in study $BNTX $MRNA $PFE https://www.thefocalpoints.com/p/first-peer-reviewed-paper-defines
0 · Reply
Quantumup
Quantumup Aug. 19 at 8:14 PM
Piper Sandler y'day🏁 $JANX Overweight-$42 and said that it continues to think JANX007 is 'a differentiated, potentially best-in-class program' in metastatic castration-resistant prostate cancer (mCRPC). $JNJ $AZN $BNTX $MRK BMY Piper Sandler said in its $JANX initiation: Following highly positive reception to JANX007 clinical data in mCRPC in December 2024, investor sentiment has waned over the course of 2025 following the emergence of competitor clinical data, and the announcement of completion of the JANX007 dose escalation. We continue to think JANX007 is a differentiated, potentially best-in-class program in mCRPC and see the stock pull-back as offering an attractive entry point as we head into the clinical update later this year.
0 · Reply
taxplanr
taxplanr Aug. 19 at 7:46 PM
For anyone who thought teaching your body to make spike proteins $BNTX $MRNA $PFE here is the spike effect guide https://cdn.shopify.com/s/files/1/0649/7658/4920/files/The_Spike_Protein_Effect_Guide-v2r.pdf
0 · Reply
taxplanr
taxplanr Aug. 19 at 10:50 AM
BREAKING there are 2 doctors in the US who care about people $BNTX $MRNA $PFE https://justthenews.com/politics-policy/health/two-physicians-sue-cdc-over-aggressive-child-vaccine-program?utm_source=mux&utm_medium=social-media&utm_campaign=social-media-autopost
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Aug. 19 at 9:47 AM
WATCHLIST AUG 19 2025 $CELZ Creative Medical Technologies will be issued US patent number 12,391,925 tomorrow titled "PREVENTION AND/OR TREATMENT OF TYPE 1 DIABETES BY AUGMENTATION OF MYELOID SUPPRESSOR CELL ACTIVITY" $TATT TAT Technologies Wins Three-Year Contract with an International Airline to Provide MRO Services For The GTCP331-500 Auxiliary Power Unit Used In The Boeing 777 Platform; Valued At $4M/Year, Or $12M $HIVE HIVE Digital Technologies Subsidiary BUZZ HPC Partners With Bell Canada To Deliver Advanced Sovereign NVIDIA AI Infrastructure For Canada $BNTX Pfizer Canada ULC And BioNTech SE Announced Today That Health Canada Has Authorized The LP. 8.1 Variant Adapted Comirnaty COVID-19 Vaccine For Individuals Aged 6 Months And Older $VSAT Viasat Secures $252M AUD Award From Geoscience Australia And Land Information New Zealand To Deliver Expanded SouthPAN Satellite Services
1 · Reply
taxplanr
taxplanr Aug. 19 at 1:17 AM
CDC being sued over illegal childhood vaccine schedule $BNTX $MRNA $PFE https://www.thefocalpoints.com/p/breaking-cdc-sued-for-pushing-illegal
2 · Reply
smartkarma
smartkarma Aug. 18 at 10:38 PM
$BNTX | BioNTech SE: An Insight Into The BNT327 Combination Trials In Oncology "The company has made significant strides in oncology, indicating a diversified approach beyond its known COVID-19 vaccine success." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/biontech-se-an-insight-into-the-bnt327-combination-trials-in-oncology
0 · Reply
taxplanr
taxplanr Aug. 18 at 4:54 PM
$BNTX $MRNA $PFE C19 bioweapons causing blindness https://www.thefocalpoints.com/p/breaking-covid-19-mrna-shots-destroy-087
2 · Reply
ZeroDayZealot
ZeroDayZealot Aug. 18 at 4:41 PM
$BNTX BioNTech's COVID vaccine windfall ends though cancer pipeline develops.
0 · Reply
taxplanr
taxplanr Aug. 18 at 2:45 PM
$BNTX $PFE $MRNA
0 · Reply
DaveOOOOOH
DaveOOOOOH Aug. 18 at 2:35 PM
$BNTX
0 · Reply
chudfendr
chudfendr Aug. 17 at 6:49 AM
$BNTX
0 · Reply
Firlefanz
Firlefanz Aug. 17 at 6:34 AM
$BNTX OMG, I'm sure that covid mrna vacc denying persons want the last glimmer of hope, if it could cure their cancer. US admin isn't farsighted
0 · Reply
taxplanr
taxplanr Aug. 16 at 1:56 PM
Swiss peer reviewed study also finds C19 boosters increases respiratory infections $BNTX $MRNA $PFE https://justthenews.com/politics-policy/coronavirus/covid-boosters-increase-influenza-illness-risk-swiss-study-finds-feds?utm_source=mux&utm_medium=social-media&utm_campaign=social-media-autopost
0 · Reply
taxplanr
taxplanr Aug. 15 at 2:41 PM
$BNTX always has the most interesting price action of the bioweapon stocks before insiders dump $PFE $MRNA
0 · Reply
tkstockpicker
tkstockpicker Aug. 15 at 2:38 PM
$BNTX Get lose you POS
0 · Reply
taxplanr
taxplanr Aug. 15 at 2:21 PM
Cool $BNTX $MRNA $PFE https://childrenshealthdefense.org/defender/breaking-hhs-reinstates-task-force-safer-childhood-vaccines-response-chd-lawsuit/
0 · Reply
taxplanr
taxplanr Aug. 15 at 10:35 AM
Another more harm than good study $BNTX $MRNA $PFE https://www.nature.com/articles/s43856-025-01046-8
1 · Reply
BarneyR
BarneyR Aug. 14 at 9:18 PM
$BNTX Huh? What's happening AH?
1 · Reply
taxplanr
taxplanr Aug. 14 at 6:49 PM
thanks $BNTX $MRNA $PFE stockholders https://www.thefocalpoints.com/p/the-whole-world-has-been-poisoned-343
1 · Reply